Qingfeng Shi

432 total citations · 1 hit paper
8 papers, 299 citations indexed

About

Qingfeng Shi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Qingfeng Shi has authored 8 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in Qingfeng Shi's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Thyroid Cancer Diagnosis and Treatment (2 papers) and Thyroid Disorders and Treatments (1 paper). Qingfeng Shi is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Thyroid Cancer Diagnosis and Treatment (2 papers) and Thyroid Disorders and Treatments (1 paper). Qingfeng Shi collaborates with scholars based in China. Qingfeng Shi's co-authors include Wen Li, Bin Huang, Ling Peng, Feng Gao, Changming Wang, Cheng-ping Hu, Jie Meng, Jiahui Wu, Qingqing Wang and Xuan Zhang and has published in prestigious journals such as Cell Death and Disease, International Journal of Nanomedicine and Infection Control and Hospital Epidemiology.

In The Last Decade

Qingfeng Shi

7 papers receiving 298 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-κB/NLRP3-mediated epithelial–mesenchymal transition and inflammation

2020 268 citations Ling Peng, Wen Li et al. Cell Death and Disease profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qingfeng Shi China	5	135	126	50	40	27	8	299
Rui Shao China	12	162 1.2×	100 0.8×	44 0.9×	26 0.7×	30 1.1×	20	362
Cheng-ping Hu China	6	156 1.2×	146 1.2×	55 1.1×	38 0.9×	25 0.9×	15	341
Changming Wang China	7	205 1.5×	146 1.2×	68 1.4×	41 1.0×	25 0.9×	10	396
Yanlin Zhang China	11	165 1.2×	68 0.5×	100 2.0×	37 0.9×	13 0.5×	24	348
Xujun Ye China	10	158 1.2×	63 0.5×	35 0.7×	54 1.4×	23 0.9×	16	293
Ling Jin China	9	159 1.2×	47 0.4×	35 0.7×	55 1.4×	20 0.7×	21	314
Di Han China	10	98 0.7×	118 0.9×	55 1.1×	20 0.5×	28 1.0×	32	328
Fanchao Feng China	10	83 0.6×	157 1.2×	23 0.5×	21 0.5×	24 0.9×	33	317
Xiaoqin Luo China	10	189 1.4×	68 0.5×	106 2.1×	50 1.3×	21 0.8×	20	415

Countries citing papers authored by Qingfeng Shi

Since Specialization

Citations

This map shows the geographic impact of Qingfeng Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingfeng Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingfeng Shi more than expected).

Fields of papers citing papers by Qingfeng Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingfeng Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingfeng Shi. The network helps show where Qingfeng Shi may publish in the future.

Co-authorship network of co-authors of Qingfeng Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Qingfeng Shi. A scholar is included among the top collaborators of Qingfeng Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingfeng Shi. Qingfeng Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Shi, Qingfeng, Wei‐Zen Sun, Xiang Chen, et al.. (2025). Epidemiology of device-associated healthcare-associated infections and carbapenem-resistant Enterobacteriaceae in intensive care units: a 7-year multicenter surveillance in Shanghai, China. Infection Control and Hospital Epidemiology. 46(10). 992–998.

2.

Qiu, Keqiang, et al.. (2025). Quercetin: A Natural Ally in Combating Breast Cancer. International Journal of Nanomedicine. Volume 20. 9155–9177. 4 indexed citations

3.

Liu, Yonghong, et al.. (2024). Thyroid Hormone Changes Correlate to Combined Breast Cancer with Primary Thyroid Cancer. Breast Cancer Targets and Therapy. Volume 16. 15–22. 4 indexed citations

4.

Liu, Yonghong, et al.. (2023). Study on Clinicopathological Features and Risk Factors of Patients with Multiple Primary Breast Cancers and Thyroid Disease. Mediators of Inflammation. 2023. 1–8. 1 indexed citations

5.

Peng, Ling, et al.. (2021). Chelerythrine Ameliorates Pulmonary Fibrosis via Activating the Nrf2/ARE Signaling Pathway. Cell Biochemistry and Biophysics. 79(2). 337–347. 12 indexed citations

6.

Wang, Qingqing, et al.. (2021). TEAD4 overexpression suppresses thyroid cancer progression and metastasis in vitro by modulating Wnt signaling. Journal of Biosciences. 47(1). 4 indexed citations

7.

Peng, Ling, Wen Li, Qingfeng Shi, et al.. (2020). Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-κB/NLRP3-mediated epithelial–mesenchymal transition and inflammation. Cell Death and Disease. 11(11). 978–978. 268 indexed citations breakdown →

8.

Cheng, Qi, et al.. (2017). Two nonsense somatic mutations in MEN1 identified in sporadic insulinomas. FEBS Open Bio. 8(2). 295–301. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact